Mitochondrial electron transport chain and transport proteins (ETC/MTP)

The mitochondrial electron transport chain (ETC) and associated transport proteins constitute the fundamental machinery for cellular energy production via oxidative phosphorylation. The ETC consists of four multi-protein complexes (I-IV) and the ATP synthase (Complex V) located in the inner mitochondrial membrane, which create a proton gradient to drive ATP synthesis [1]. Transport proteins, such as the adenine nucleotide translocator (ANT) and the voltage-dependent anion channel (VDAC), facilitate the exchange of metabolites, ions, and nucleotides between the mitochondria and the cytosol [2]. Dysregulation of these components is central to the pathogenesis of mitochondrial diseases, neurodegenerative disorders like Parkinson's, and metabolic syndromes [3]. Pharmacological targeting of these systems includes the use of biguanides like metformin to inhibit Complex I for diabetes management, or the development of VDAC modulators for cancer therapy [4]. However, because these proteins are essential for systemic energy metabolism, targeting them carries significant risks of toxicity and metabolic acidosis [5]. This entry is considered incorrect as a single target because it aggregates dozens of distinct enzymes and transporters into a single functional category [1,2]. Sources: [1] Wikipedia: Electron transport chain [2] UniProt: Mitochondrial carrier family (SLC25) [3] NIH/PubMed: Mitochondrial dysfunction in disease (PMID: 23899561) [4] PubChem: Metformin (CID 4091) [5] StatPearls: Mitochondrial Myopathy

Other names

Oxidative phosphorylation systemOXPHOSMitochondrial respiratory chainMitochondrial carrier familyMitochondrial solute carriers

Inhibition of electron flow through complexes I-IV, uncoupling of the proton gradient from ATP synthesis, and modulation of metabolite transport across the inner mitochondrial membrane.